Last reviewed · How we verify
Tivicay 50mg, film-coated tablets
Tivicay 50mg, film-coated tablets is a Small molecule drug developed by Humanis Saglık Anonim Sirketi. It is currently in Phase 1 development.
At a glance
| Generic name | Tivicay 50mg, film-coated tablets |
|---|---|
| Sponsor | Humanis Saglık Anonim Sirketi |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Study to Evaluate the Efficacy, Safety, and Tolerability of Long-acting Intramuscular Cabotegravir and Rilpivirine for Maintenance of Virologic Suppression Following Switch From an Integrase Inhibitor in HIV-1 Infected Therapy Naive Participants (PHASE3)
- Bioequivalence Study to Compare Dolutegravir 50mg Film-coated Tablets (PHASE1)
- Development of a Urine-Based Point-of-Care Test for Adherence to Antiretroviral Drugs (EARLY_PHASE1)
- Study to Evaluate the Safety and PK of Elpida® in Healthy Subjects and Patients With Hepatic Impairment and to Assess the Impact of Food Intake and Drug-Drug Interactions With Other Antiviral Drugs (PHASE1)
- Rapid Test and Treat Dolutegravir Plus Lamivudine Study in Newly Diagnosed Human Immunodeficiency Virus (HIV)-1 Infected Adults (PHASE3)
- Relative Bio-availability Study of Dolutegravir and Lamivudine Fixed Dose Combinations (PHASE1)
- Study to Evaluate the Drug Interaction Between Dolutegravir (DTG) and Daclatasvir (DCV) in Healthy Adult Subjects (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Tivicay 50mg, film-coated tablets CI brief — competitive landscape report
- Tivicay 50mg, film-coated tablets updates RSS · CI watch RSS
- Humanis Saglık Anonim Sirketi portfolio CI
Frequently asked questions about Tivicay 50mg, film-coated tablets
What is Tivicay 50mg, film-coated tablets?
Tivicay 50mg, film-coated tablets is a Small molecule drug developed by Humanis Saglık Anonim Sirketi.
Who makes Tivicay 50mg, film-coated tablets?
Tivicay 50mg, film-coated tablets is developed by Humanis Saglık Anonim Sirketi (see full Humanis Saglık Anonim Sirketi pipeline at /company/humanis-sagl-k-anonim-sirketi).
What development phase is Tivicay 50mg, film-coated tablets in?
Tivicay 50mg, film-coated tablets is in Phase 1.